Pharma & Healthcare

Global Ioversol Injection Market Research Report 2026

This report delivers a comprehensive overview of the global Ioversol Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Ioversol Injection. The Ioversol Injection market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Ioversol Injection market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Ioversol Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
GUERBET
Liebel-Flarsheim Company LLC
Hengrui Pharmaceuticals
Neptunus Bio-pharmaceutical
Bayer HealthCare Pharmaceuticals
Bracco Imaging S.p.A.
Zhejiang Starry Pharmaceutical
Segment by Type
50mL
75mL
100mL
125mL
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Ioversol Injection companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ioversol Injection Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 50mL
1.2.3 75mL
1.2.4 100mL
1.2.5 125mL
1.3 Market by Application
1.3.1 Global Ioversol Injection Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ioversol Injection Market Perspective (2021–2032)
2.2 Global Ioversol Injection Growth Trends by Region
2.2.1 Global Ioversol Injection Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Ioversol Injection Historic Market Size by Region (2021–2026)
2.2.3 Ioversol Injection Forecasted Market Size by Region (2027–2032)
2.3 Ioversol Injection Market Dynamics
2.3.1 Ioversol Injection Industry Trends
2.3.2 Ioversol Injection Market Drivers
2.3.3 Ioversol Injection Market Challenges
2.3.4 Ioversol Injection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ioversol Injection Players by Revenue
3.1.1 Global Top Ioversol Injection Players by Revenue (2021–2026)
3.1.2 Global Ioversol Injection Revenue Market Share by Players (2021–2026)
3.2 Global Top Ioversol Injection Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Ioversol Injection Revenue
3.4 Global Ioversol Injection Market Concentration Ratio
3.4.1 Global Ioversol Injection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ioversol Injection Revenue in 2025
3.5 Global Key Players of Ioversol Injection Head Offices and Areas Served
3.6 Global Key Players of Ioversol Injection, Products and Applications
3.7 Global Key Players of Ioversol Injection, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Ioversol Injection Breakdown Data by Type
4.1 Global Ioversol Injection Historic Market Size by Type (2021–2026)
4.2 Global Ioversol Injection Forecasted Market Size by Type (2027–2032)
5 Ioversol Injection Breakdown Data by Application
5.1 Global Ioversol Injection Historic Market Size by Application (2021–2026)
5.2 Global Ioversol Injection Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Ioversol Injection Market Size (2021–2032)
6.2 North America Ioversol Injection Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Ioversol Injection Market Size by Country (2021–2026)
6.4 North America Ioversol Injection Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ioversol Injection Market Size (2021–2032)
7.2 Europe Ioversol Injection Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Ioversol Injection Market Size by Country (2021–2026)
7.4 Europe Ioversol Injection Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Ioversol Injection Market Size (2021–2032)
8.2 Asia-Pacific Ioversol Injection Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Ioversol Injection Market Size by Region (2021–2026)
8.4 Asia-Pacific Ioversol Injection Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Ioversol Injection Market Size (2021–2032)
9.2 Latin America Ioversol Injection Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Ioversol Injection Market Size by Country (2021–2026)
9.4 Latin America Ioversol Injection Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ioversol Injection Market Size (2021–2032)
10.2 Middle East & Africa Ioversol Injection Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Ioversol Injection Market Size by Country (2021–2026)
10.4 Middle East & Africa Ioversol Injection Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GUERBET
11.1.1 GUERBET Company Details
11.1.2 GUERBET Business Overview
11.1.3 GUERBET Ioversol Injection Introduction
11.1.4 GUERBET Revenue in Ioversol Injection Business (2021–2026)
11.1.5 GUERBET Recent Development
11.2 Liebel-Flarsheim Company LLC
11.2.1 Liebel-Flarsheim Company LLC Company Details
11.2.2 Liebel-Flarsheim Company LLC Business Overview
11.2.3 Liebel-Flarsheim Company LLC Ioversol Injection Introduction
11.2.4 Liebel-Flarsheim Company LLC Revenue in Ioversol Injection Business (2021–2026)
11.2.5 Liebel-Flarsheim Company LLC Recent Development
11.3 Hengrui Pharmaceuticals
11.3.1 Hengrui Pharmaceuticals Company Details
11.3.2 Hengrui Pharmaceuticals Business Overview
11.3.3 Hengrui Pharmaceuticals Ioversol Injection Introduction
11.3.4 Hengrui Pharmaceuticals Revenue in Ioversol Injection Business (2021–2026)
11.3.5 Hengrui Pharmaceuticals Recent Development
11.4 Neptunus Bio-pharmaceutical
11.4.1 Neptunus Bio-pharmaceutical Company Details
11.4.2 Neptunus Bio-pharmaceutical Business Overview
11.4.3 Neptunus Bio-pharmaceutical Ioversol Injection Introduction
11.4.4 Neptunus Bio-pharmaceutical Revenue in Ioversol Injection Business (2021–2026)
11.4.5 Neptunus Bio-pharmaceutical Recent Development
11.5 Bayer HealthCare Pharmaceuticals
11.5.1 Bayer HealthCare Pharmaceuticals Company Details
11.5.2 Bayer HealthCare Pharmaceuticals Business Overview
11.5.3 Bayer HealthCare Pharmaceuticals Ioversol Injection Introduction
11.5.4 Bayer HealthCare Pharmaceuticals Revenue in Ioversol Injection Business (2021–2026)
11.5.5 Bayer HealthCare Pharmaceuticals Recent Development
11.6 Bracco Imaging S.p.A.
11.6.1 Bracco Imaging S.p.A. Company Details
11.6.2 Bracco Imaging S.p.A. Business Overview
11.6.3 Bracco Imaging S.p.A. Ioversol Injection Introduction
11.6.4 Bracco Imaging S.p.A. Revenue in Ioversol Injection Business (2021–2026)
11.6.5 Bracco Imaging S.p.A. Recent Development
11.7 Zhejiang Starry Pharmaceutical
11.7.1 Zhejiang Starry Pharmaceutical Company Details
11.7.2 Zhejiang Starry Pharmaceutical Business Overview
11.7.3 Zhejiang Starry Pharmaceutical Ioversol Injection Introduction
11.7.4 Zhejiang Starry Pharmaceutical Revenue in Ioversol Injection Business (2021–2026)
11.7.5 Zhejiang Starry Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Ioversol Injection Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of 50mL
Table 3. Key Players of 75mL
Table 4. Key Players of 100mL
Table 5. Key Players of 125mL
Table 6. Global Ioversol Injection Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Ioversol Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Ioversol Injection Market Size by Region (US$ Million), 2021–2026
Table 9. Global Ioversol Injection Market Share by Region (2021–2026)
Table 10. Global Ioversol Injection Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Ioversol Injection Market Share by Region (2027–2032)
Table 12. Ioversol Injection Market Trends
Table 13. Ioversol Injection Market Drivers
Table 14. Ioversol Injection Market Challenges
Table 15. Ioversol Injection Market Restraints
Table 16. Global Ioversol Injection Revenue by Players (US$ Million), 2021–2026
Table 17. Global Ioversol Injection Market Share by Players (2021–2026)
Table 18. Global Top Ioversol Injection Players by Tier (Tier 1, Tier 2, and Tier 3), based on Ioversol Injection Revenue, 2025
Table 19. Ranking of Global Top Ioversol Injection Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Ioversol Injection Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Ioversol Injection, Headquarters and Area Served
Table 22. Global Key Players of Ioversol Injection, Products and Applications
Table 23. Global Key Players of Ioversol Injection, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Ioversol Injection Market Size by Type (US$ Million), 2021–2026
Table 26. Global Ioversol Injection Revenue Market Share by Type (2021–2026)
Table 27. Global Ioversol Injection Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Ioversol Injection Revenue Market Share by Type (2027–2032)
Table 29. Global Ioversol Injection Market Size by Application (US$ Million), 2021–2026
Table 30. Global Ioversol Injection Revenue Market Share by Application (2021–2026)
Table 31. Global Ioversol Injection Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Ioversol Injection Revenue Market Share by Application (2027–2032)
Table 33. North America Ioversol Injection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Ioversol Injection Market Size by Country (US$ Million), 2021–2026
Table 35. North America Ioversol Injection Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Ioversol Injection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Ioversol Injection Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Ioversol Injection Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Ioversol Injection Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Ioversol Injection Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Ioversol Injection Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Ioversol Injection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Ioversol Injection Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Ioversol Injection Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Ioversol Injection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Ioversol Injection Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Ioversol Injection Market Size by Country (US$ Million), 2027–2032
Table 48. GUERBET Company Details
Table 49. GUERBET Business Overview
Table 50. GUERBET Ioversol Injection Product
Table 51. GUERBET Revenue in Ioversol Injection Business (US$ Million), 2021–2026
Table 52. GUERBET Recent Development
Table 53. Liebel-Flarsheim Company LLC Company Details
Table 54. Liebel-Flarsheim Company LLC Business Overview
Table 55. Liebel-Flarsheim Company LLC Ioversol Injection Product
Table 56. Liebel-Flarsheim Company LLC Revenue in Ioversol Injection Business (US$ Million), 2021–2026
Table 57. Liebel-Flarsheim Company LLC Recent Development
Table 58. Hengrui Pharmaceuticals Company Details
Table 59. Hengrui Pharmaceuticals Business Overview
Table 60. Hengrui Pharmaceuticals Ioversol Injection Product
Table 61. Hengrui Pharmaceuticals Revenue in Ioversol Injection Business (US$ Million), 2021–2026
Table 62. Hengrui Pharmaceuticals Recent Development
Table 63. Neptunus Bio-pharmaceutical Company Details
Table 64. Neptunus Bio-pharmaceutical Business Overview
Table 65. Neptunus Bio-pharmaceutical Ioversol Injection Product
Table 66. Neptunus Bio-pharmaceutical Revenue in Ioversol Injection Business (US$ Million), 2021–2026
Table 67. Neptunus Bio-pharmaceutical Recent Development
Table 68. Bayer HealthCare Pharmaceuticals Company Details
Table 69. Bayer HealthCare Pharmaceuticals Business Overview
Table 70. Bayer HealthCare Pharmaceuticals Ioversol Injection Product
Table 71. Bayer HealthCare Pharmaceuticals Revenue in Ioversol Injection Business (US$ Million), 2021–2026
Table 72. Bayer HealthCare Pharmaceuticals Recent Development
Table 73. Bracco Imaging S.p.A. Company Details
Table 74. Bracco Imaging S.p.A. Business Overview
Table 75. Bracco Imaging S.p.A. Ioversol Injection Product
Table 76. Bracco Imaging S.p.A. Revenue in Ioversol Injection Business (US$ Million), 2021–2026
Table 77. Bracco Imaging S.p.A. Recent Development
Table 78. Zhejiang Starry Pharmaceutical Company Details
Table 79. Zhejiang Starry Pharmaceutical Business Overview
Table 80. Zhejiang Starry Pharmaceutical Ioversol Injection Product
Table 81. Zhejiang Starry Pharmaceutical Revenue in Ioversol Injection Business (US$ Million), 2021–2026
Table 82. Zhejiang Starry Pharmaceutical Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 86. Authors List of This Report


List of Figures
Figure 1. Ioversol Injection Picture
Figure 2. Global Ioversol Injection Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Ioversol Injection Market Share by Type: 2025 vs 2032
Figure 4. 50mL Features
Figure 5. 75mL Features
Figure 6. 100mL Features
Figure 7. 125mL Features
Figure 8. Global Ioversol Injection Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Ioversol Injection Market Share by Application: 2025 vs 2032
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Ioversol Injection Report Years Considered
Figure 14. Global Ioversol Injection Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Ioversol Injection Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Ioversol Injection Market Share by Region: 2025 vs 2032
Figure 17. Global Ioversol Injection Market Share by Players in 2025
Figure 18. Global Ioversol Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Ioversol Injection Revenue in 2025
Figure 20. North America Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Ioversol Injection Market Share by Country (2021–2032)
Figure 22. United States Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Ioversol Injection Market Share by Country (2021–2032)
Figure 26. Germany Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Ioversol Injection Market Share by Region (2021–2032)
Figure 34. China Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Ioversol Injection Market Share by Country (2021–2032)
Figure 42. Mexico Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Ioversol Injection Market Share by Country (2021–2032)
Figure 46. Israel Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Ioversol Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. GUERBET Revenue Growth Rate in Ioversol Injection Business (2021–2026)
Figure 50. Liebel-Flarsheim Company LLC Revenue Growth Rate in Ioversol Injection Business (2021–2026)
Figure 51. Hengrui Pharmaceuticals Revenue Growth Rate in Ioversol Injection Business (2021–2026)
Figure 52. Neptunus Bio-pharmaceutical Revenue Growth Rate in Ioversol Injection Business (2021–2026)
Figure 53. Bayer HealthCare Pharmaceuticals Revenue Growth Rate in Ioversol Injection Business (2021–2026)
Figure 54. Bracco Imaging S.p.A. Revenue Growth Rate in Ioversol Injection Business (2021–2026)
Figure 55. Zhejiang Starry Pharmaceutical Revenue Growth Rate in Ioversol Injection Business (2021–2026)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies